0001140361-24-035394.txt : 20240801 0001140361-24-035394.hdr.sgml : 20240801 20240801180927 ACCESSION NUMBER: 0001140361-24-035394 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240730 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Backus William A. CENTRAL INDEX KEY: 0001530884 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13648 FILM NUMBER: 241168211 MAIL ADDRESS: STREET 1: 52 SUNRISE PARK ROAD CITY: NEW HAMPTON STATE: NY ZIP: 10958 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BALCHEM CORP CENTRAL INDEX KEY: 0000009326 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 132578432 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARAGON DRIVE CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: (845) 326-5600 MAIL ADDRESS: STREET 1: 5 PARAGON DRIVE CITY: MONTVALE STATE: NJ ZIP: 07645 4 1 form4.xml FORM 4 X0508 4 2024-07-30 0000009326 BALCHEM CORP BCPC 0001530884 Backus William A. C/O BALCHEM CORPORATION 5 PARAGON DRIVE MONTVALE NJ 07645 true VP & Chief Accounting Officer false Common Stock 2024-07-30 4 M 0 3900 84.09 A 8888 D Common Stock 2024-07-30 4 S 0 3570 179.247 D 5318 D Common Stock 2024-07-30 4 S 0 330 180.4656 D 4988 D Common Stock 2024-07-30 4 S 0 904 177.0955 D 132 I 401(k) Plan Stock Options (right to buy) 84.09 2024-07-30 4 M 0 3900 0 D 2029-02-13 Common Stock 3900 0 D Exercise of fully vested non-qualified stock options. This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan. Reflects shares previously acquired under the Balchem Corporation 401(k) plan. Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable. /s/ Travis Larsen, Attorney in Fact for William A Backus 2024-08-01